Arboreal Bioinnovations, a Lucknow-based B2B supplier of functional food ingredients, has raised ₹230 Cr (approximately $24 Mn) in a Series A round co-led by EAAA Alternatives and Omnivore. Zerodha's Rainmatter, an existing investor, also participated. The capital will fund expanded manufacturing capacity, deeper R&D, and faster commercialisation of new ingredient lines.
What Arboreal actually makes
Arboreal Stevia Raises ₹230 Cr to Scale India’s Specialty Ingredients | Startup Street
Founded in 2018 by Swati Pandey and Manish Chauhan, Arboreal develops proprietary functional ingredients for food, beverage, and nutraceutical brands. Its portfolio covers proteins, cocoa-based ingredients, natural zero-calorie sweeteners, and functional fibres. The company currently sells five flagship products: Pyure, Bioprot, COCOCO, Evo, and Ori. Several more are in development.
Arboreal claims to serve more than 1,100 consumer brands and nutraceutical manufacturers. Over the past 18 months, its ingredients have powered more than 300 product launches, according to the company.
"This fundraise gives us the ability to invest more deeply in science, manufacturing, talent and long-term innovation, while building a platform capable of creating differentiated ingredients for some of the world's most important food and nutraceutical brands," said co-founder Manish Chauhan.
Why investors are paying attention to B2B ingredients
The round reflects growing demand for clean-label, functional, and science-backed food inputs. Brands across India and globally are increasingly focused on protein enrichment, sugar reduction, and gut-health products. India's specialty food ingredients market is projected to grow steadily over the coming years, opening opportunities for ingredient manufacturers serving both domestic and international customers.
Arboreal's model differs from D2C nutrition startups. It does not sell finished products to consumers. Instead, it supplies the raw ingredients that brands use to formulate their own protein bars, low-sugar drinks, and dietary supplements. That B2B positioning insulates it from direct consumer-acquisition costs while riding the same underlying demand.
How the D2C nutrition segment compares
The broader D2C nutrition space continues to attract capital. In June 2026, D2C brand TruNative raised $30 Mn in a Series B led by OrbiMed to expand offline retail. Earlier this year, Good Monk secured ₹33 Cr to scale its portfolio of dietary supplements, functional drink mixes, and plant-based protein products.
Arboreal sits upstream from these players. If D2C brands are the storefronts, Arboreal is the factory floor. A bet on Arboreal is a bet that whoever wins the consumer-facing race will still need specialty ingredients.
Logicity's Take
B2B ingredient plays are often quieter than D2C brands, but they carry lower customer-acquisition risk and benefit from sticky, contract-based revenue. For finance teams tracking the nutrition space, Arboreal's round signals that upstream value capture is attracting institutional interest. Watch whether Arboreal can defend margins as D2C brands pressure supplier pricing, and whether its 1,100-brand claim translates into durable repeat orders.
What the funding does not reveal
The announcement omits revenue figures, gross margins, and the valuation at which the round closed. Arboreal has not disclosed what share of its 1,100 customers generate meaningful recurring revenue versus one-off orders. The timeline for the new ingredients under development is also unclear.
Investors in B2B food ingredients typically expect 30-50% gross margins and multi-year supply contracts. Whether Arboreal has achieved that profile remains undisclosed.
Need Help Implementing This?
Have a question about tracking funding rounds in your sector or building financial models for B2B startups? Reach out to Logicity's team at hello@logicity.in.
Source: Inc42 Media / Palak Sharma
Huma Shazia
Senior AI & Tech Writer
Produced with AI assistance and reviewed by the Logicity editorial team. Learn more in our Editorial Policy.
